Browse studies

Find your next paid study

27,293 recruiting studies available now

Nonoperative vs. Surgical Decompression for Mild-to-Moderate Cubital Tunnel Syndrome: A Prospective Randomized Controlled Trial

Cubital tunnel syndrome is a condition that occurs when the ulnar nerve, which runs along the inside of the elbow, becomes irritated or compressed. It can caus…

Cubital Tunnel Syndrome

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PittsburghNCT07862543

Phase 3

A Randomized, Multi-center, Double-blind, Sham-controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Intrathecally Administered Rugonersen in Pediatric and Adult Participants With Angelman Syndrome

Purpose of the study is to evaluate the efficacy and safety of intrathecally administered rugonersen in pediatric and adult participants with Angelman syndrome.

Angelman Syndrome

Estimated

~$50 – $2,100

Actual pay is set by the research site.

OHB Pediatrics Ltd.NCT07605429

Observational

Enduring Migraine Benefit From Responsive Artery Coil Embolization (EMBRACE): A Single-Site, Non-Significant Risk Pilot Study of Middle Meningeal Artery Embolization Using FDA-Cleared Coils for Refractory Episodic Migraine

This single-site, open-label pilot study evaluates the safety, feasibility, and potential durability of the TEMMA procedure (Targeted Embolization for Migraine…

Migraine DisordersRefractory MigraineChronic Migraine

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Cortex NeurovascularNCT07313800

Observational

Adapting Exposure Therapy to Target Anxiety About Weight Gain in Adolescents With Anorexia Nervosa

This pilot study is evaluating Exposure Therapy (Exp-AN) as a virtual treatment for adolescents (ages 14 - 17 years) with anorexia nervosa (AN) recruited from …

Anorexia Nervosa

Estimated

~$10 – $750

Actual pay is set by the research site.

Milton S. Hershey Medical CenterNCT07188155

Phase 1

A Phase 1b Open-Label Study to Evaluate the Safety and Tolerability of Eganelisib as Monotherapy and in Combination With Cytarabine in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Higher Risk Myelodysplastic Syndrome and Eganelisib in Combination With Azacitidine in PI3K-Gamma-Positive Patients With Previously Untreated Higher Risk Myelodysplastic Syndrome

This is a Phase 1b open-label, multicenter, dose-escalation and randomized combination cohort study designed to evaluate the safety, tolerability, pharmacokine…

AML, AdultMDS

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Stelexis BioSciencesNCT06533761

Observational

Participant Engagement - Cancer Genome Sequencing (PE-CGS) Research Center: Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American In…

Malignant Neoplasm

Estimated

~$10 – $1,125

Actual pay is set by the research site.

New Mexico Cancer Research AllianceNCT06207864

Phase 4

GLOW (GLP-1 Plus Lifestyle for Overall Wellness)

The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with ob…

Obesity, Childhood

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of MinnesotaNCT06977438

Phase 1

An Open-Label, Multicenter, Phase Ib Trial Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab as Monotherapy and Cevostamab Plus Pomalidomide and Dexamethasone or Cevostamab Plus Daratumumab and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

This Phase Ib, multicenter, open-label study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of cevostamab monotherapy…

Multiple Myeloma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Genentech, Inc.NCT04910568

Phase 1

A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer

Researchers are looking for new ways to treat extensive-stage small cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread throughout the…

Small Cell Lung Cancer Extensive Stage

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07227597

Observational

Preventing Depression of Chinese American Adolescents Through Mobile Health Application

The goal of this clinical trial is to test if a culturally sensitive mobile health application (Relax, Reflect, Empower-RRE) is feasible and effective in promo…

Subclinical Depressive Symptoms

Estimated

~$10 – $750

Actual pay is set by the research site.

Northeastern UniversityNCT05921201

Phase 4

A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, …

Ulcerative ColitisCrohn's Disease

Estimated

~$25 – $1,500

Actual pay is set by the research site.

TakedaNCT06581328

Phase 3

A Randomized, Open-label, Phase 3 Study of Setidegrasib (ASP3082) Versus Docetaxel in Participants With KRAS G12D-mutated Locally Advanced (Unresectable) or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on or After Platinum Based Chemotherapy and Checkpoint Inhibitor Therapy (CPI)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. The first treatment is usually chemotherapy, given with another treatment that targe…

Non-small Cell Lung Cancer (NSCLC)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Astellas Pharma Global Development, Inc.NCT07566052